Paper333953
L-tryptophan in obsessive-compulsive disorders.
Yaryura-Tobias JA and 1 other. Am J Psychiatry, 1977. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. L-tryptophan in obsessive-compulsive disorders. Papers, record 333953. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/333953
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Obsessive-Compulsive Disorder | Major topic |
| Tryptophan | Major topic |
| Adolescent | |
| Adult | |
| Aggression | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Male | |
| Remission, Spontaneous |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33975093 | Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder. | Psychiatry Res | 2021 | https://conductscience.org/library/papers/33975093 | PubMed |
| 29871422 | Obsessive-compulsive disorder in children and adolescents. A review of the literature. | Eur Child Adolesc Psychiatry | 1994 | https://conductscience.org/library/papers/29871422 | PubMed |
| 18208598 | Nutritional therapies for mental disorders. | Nutr J | 2008 | https://conductscience.org/library/papers/18208598 | PubMed |
| 8814411 | Treatment of obsessive-compulsive disorder in children and adolescents. A review of the literature. | Eur Child Adolesc Psychiatry | 1996 | https://conductscience.org/library/papers/8814411 | PubMed |
| 3133689 | Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects. | Psychopharmacology (Berl) | 1988 | https://conductscience.org/library/papers/3133689 | PubMed |
| 2178909 | Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. | Drugs | 1990 | https://conductscience.org/library/papers/2178909 | PubMed |
| 1706983 | 5-HT1A partial agonists. What is their future? | Drugs | 1991 | https://conductscience.org/library/papers/1706983 | PubMed |
| 1372219 | Current concepts in the pharmacological treatment of obsessive-compulsive disorder. | Drugs | 1992 | https://conductscience.org/library/papers/1372219 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/333953
GET https://conductscience.org/api/papers/v1/333953/authors